Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin GB0009252882
Ticker GSK.L
Company GLAXOSMITHKLINE
Currency £
Price
Aware Investor Index (AII) 1,228.6635
Recommendation STRONG BUY
P/E 17.73
ROE 100.00 %
Capitalization 100,041,703,260 $
Dividend Yield 5.12 %
P/S 2.56
AII Position 4
P/E Position 198
ROE Position 23
Capitalization Position 76
Dividend Yield Position 87
Sales 30,186,000,000 £
10-Year Average Earnings 4,356,000,000 £
Shares Outstanding 4,941,000,000
Equity -68,000,000 £
Dividend per Share 0.8 £
Industry Pharmaceutical
Country Great Britain
GLAXOSMITHKLINE Investor Relations Web Site http://www.gsk.com/investors.html







Sales:

YEAR MONTH AMOUNT
2017 12 30,186,000,000.00 £
2016 12 27,889,000,000.00 £
2015 12 23,923,000,000.00 £
2014 12 23,006,000,000.00 £
2013 12 26,505,000,000.00 £

Earnings:

YEAR MONTH AMOUNT
2017 12 1,532,000,000.00 £
2016 12 912,000,000.00 £
2015 12 8,422,000,000.00 £
2014 12 2,756,000,000.00 £
2013 12 5,436,000,000.00 £
2012 12 4,499,000,000.00 £
2011 12 5,208,000,000.00 £
2010 12 2,961,000,000.00 £
2009 12 6,283,000,000.00 £
2008 12 5,551,000,000.00 £

Equity:

YEAR MONTH AMOUNT
2017 12 -68,000,000.00 £
2016 12 1,124,000,000.00 £
2015 12 5,114,000,000.00 £
2014 12 4,263,000,000.00 £
2013 12 7,812,000,000.00 £
2012 12 6,747,000,000.00 £
2011 12 8,827,000,000.00 £
2010 12 9,745,000,000.00 £
2009 12 10,742,000,000.00 £
2008 12 8,318,000,000.00 £

Shares Outstanding:

YEAR MONTH AMOUNT
2017 12 4,941,000,000
2016 12 4,909,000,000
2015 12 4,888,000,000
2014 12 4,865,000,000
2013 12 4,919,000,000
2012 12 4,913,000,000
2011 12 5,099,000,000
2010 12 5,128,000,000
2009 12 5,108,000,000
2008 12 5,226,000,000

 












Bloomberg News for GLAXOSMITHKLINE:



Google News for GLAXOSMITHKLINE:

Bay City Observer - 2 days ago
Glaxosmithkline Plc (GSK.L): Numbers in Focus
Focusing in on the signals for Glaxosmithkline Plc (GSK.L), we have recently seen that the Kaufman Adaptive Moving Average is trending up ...
Stock Voice - 1 day ago
Performance Focus: Glaxosmithkline Plc (GSK.L) Shares Higher ...
Zooming in on shares of Glaxosmithkline Plc (GSK.L) we have seen that the stock price has gained 4.41% over the last 4-weeks. If we look ...
Lakeland Observer - 9 Nov 2018
Technical Watch: SuperTrend Noted Below Stock Price for ...
The SuperTrend signal is presently lower than the stock price for Glaxosmithkline Plc (GSK.L). Active traders may be carefully tracking the ...
Lakeland Observer - 27 Oct 2018
Technicals on Watch For Glaxosmithkline Plc (GSK.L)
Shares of Glaxosmithkline Plc (GSK.L) are heading in a near-term positive direction as the most recent close of the company has stayed above ...
Lakeland Observer - 5 days ago
Stock Under Review: Looking at the $1535.09 Pivot Levels for ...
Watching some technical levels for Glaxosmithkline Plc (GSK.L), we have noticed that the current 20-Day Bollinger Bands signal is reading ...
Lakeland Observer - 23 Oct 2018
What the MFI Reveals About Glaxosmithkline Plc (GSK.L)
Glaxosmithkline Plc (GSK.L) shares have sparked the interest of some chartists as the Money Flow Index has dropped below 30, potentially ...
Markets Insider - 21 Oct 2018
GSK Presents Data Of Anti GM-CSF Antibody In Patients With ...
(RTTNews) - GlaxoSmithKline plc (GSK, GSK.L) announced encouraging results from a phase II dose-ranging study of GSK3196165 or ...
euronews - 31 Oct 2018
GSK feels shingles vaccine boost, but shares slip on drugs mix
LONDON (Reuters) - GlaxoSmithKline's <GSK.L> third-quarter earnings were lifted by demand for its new shingles vaccine on Wednesday, but ...
Nasdaq
Smith Moore & Company Holds Position in Wells Fargo Co New ...
11.8B RUPEES; 23/03/2018 – GLAXOSMITHKLINE PLC GSK.L – VIIV HEALTHCARE GAINS CHMP POSITIVE OPINION FOR JULUCA ...
EN Digest - 10 hours ago
As Glaxosmithkline Plc (GSK) Stock Declined, Tower Research ...
As Glaxosmithkline Plc (GSK) Stock Declined, Tower Research Capital Trc ... GSK; 25/04/2018 – GLAXOSMITHKLINE GSK.L NEW R&D HEAD ...


Back